NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) (351692)

    From US Department of Health & Human Services: National Institutes of Health (NIH)

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

    Type of Support

    Overview

    The grant aims to support investigator-initiated, high-risk multi-center clinical studies in areas relevant to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Through a two-part process that may include an implementation planning cooperative agreement (U34), it focuses on permitting early peer review of the proposed study's rationale, assessing the study's design and protocol, providing support for the development of essential documents such as operation manuals, and supporting other key elements necessary for conducting the clinical study. The clinical study must be hypothesis-driven and relate to a disease within the NIDDK’s mission. Applicants are strongly encouraged to consult with NIDDK scientific staff prior to submission.

    Eligibility

    Organization's Location
    nulla adipisicing, nisi duis, est ad, qui consectetur, sunt occaecat, aute qui
    Program Location
    nulla proident voluptate deserunt reprehenderit proident deserunt consectetur commodo dolor
    Organization Type
    up to 450K

    Submission

    Visit Apply for more information.

    Similar grants